Citation 75089

GARLASCHELLI,L: VIDARI,G: VIRTUANI,M: VITA-FINZI,P: MELLERIO,G:. (1995). THE STRUCTURES OF NEW LANOSTANE TRITERPENES FROM THE FRUITING BODIES OF HEBELOMA SENESCENS.. 58(7)

Citation Details

Title	THE STRUCTURES OF NEW LANOSTANE TRITERPENES FROM THE FRUITING BODIES OF HEBELOMA SENESCENS.
Authors	GARLASCHELLI,L: VIDARI,G: VIRTUANI,M: VITA-FINZI,P: MELLERIO,G:
Year	1995
Volume	58
Issue	7

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (1)

Hebeloma senescens (CORTINARIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HEBELOMIC ACID B	None
2	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEBELOMIC ACID B	ACTIVE
3	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEBELOMIC ACID B	ACTIVE
4	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEBELOMIC ACID B	ACTIVE
5	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEBELOMIC ACID B	INACTIVE
6	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HEBELOMIC ACID B	WEAK ACTIVITY
7	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HEBELOMIC ACID E	None
8	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HEBELOMIC ACID F	None
9	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEBELOMIC ACID E	ACTIVE
10	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEBELOMIC ACID E	ACTIVE
11	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEBELOMIC ACID F	ACTIVE
12	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEBELOMIC ACID E	INACTIVE
13	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HEBELOMIC ACID E	ACTIVE
14	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HEBELOMIC ACID A	None
15	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEBELOMIC ACID A	ACTIVE
16	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEBELOMIC ACID A	ACTIVE
17	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEBELOMIC ACID A	ACTIVE
18	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEBELOMIC ACID A	INACTIVE
19	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HEBELOMIC ACID A	ACTIVE

Show SPARQL Queries (1)